Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Treace Medical Concepts, Inc. before investing.

In this article, we go over a few key elements for understanding Treace Medical Concepts, Inc.’s stock price such as:

• Treace Medical Concepts, Inc.’s current stock price and volume
• Why Treace Medical Concepts, Inc.’s stock price changed recently
• Upgrades and downgrades for TMCI from analysts
• TMCI’s stock price momentum as measured by its relative strength

About Treace Medical Concepts, Inc. (TMCI)

Before we jump into Treace Medical Concepts, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Want to learn more about Treace Medical Concepts, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Treace Medical Concepts, Inc..

Treace Medical Concepts, Inc.’s Stock Price as of Market Close

As of May 14, 2026, 9:59 AM, CST, Treace Medical Concepts, Inc.’s stock price was $2.555.

Treace Medical Concepts, Inc. is up 0.99% from its previous closing price of $2.530.

During the last market session, Treace Medical Concepts, Inc.’s stock traded between $2.490 and $2.630. Currently, there are approximately 64.59 million shares outstanding for Treace Medical Concepts, Inc..

Treace Medical Concepts, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Treace Medical Concepts, Inc. Stock Price History

Treace Medical Concepts, Inc.’s (TMCI) price is currently up 41.16% so far this month.

During the month of May, Treace Medical Concepts, Inc.’s stock price has reached a high of $2.630 and a low of $1.740.

Over the last year, Treace Medical Concepts, Inc. has hit prices as high as $7.780 and as low as $1.170. Year to date, Treace Medical Concepts, Inc.’s stock is up 4.29%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Treace Medical Concepts, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 13, 2026, there was 1 analyst who downgraded Treace Medical Concepts, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Treace Medical Concepts, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Treace Medical Concepts, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Treace Medical Concepts, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Treace Medical Concepts, Inc. (TMCI) by visiting AAII Stock Evaluator.

Relative Price Strength of Treace Medical Concepts, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 13, 2026, Treace Medical Concepts, Inc. has a weighted four-quarter relative price strength of -12.60%, which translates to a Momentum Score of 22 and is considered to be Weak.

Want to learn more about how Treace Medical Concepts, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Treace Medical Concepts, Inc. Stock Price: Bottom Line

As of May 14, 2026, Treace Medical Concepts, Inc.’s stock price is $2.555, which is up 0.99% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Treace Medical Concepts, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.